PMID: 7540416May 1, 1995Paper

The effect of continuous G-CSF application in human cyclic neutropenia: a model analysis

British Journal of Haematology
S SchmitzV Diehl

Abstract

Human cyclic neutropenia (CN) is a rare haematological disorder characterized by oscillations of blood neutrophils at subnormal levels with a stable period of approximately 21 d. During the phase of severe neutropenia (neutrophils < 250 cells/microliters), which last 4-10 d, the patients are endangered by serious infections. Several authors report that continuous G-CSF application can elevate the blood neutrophils to such a level that the risk of infections is significantly reduced. Although the characteristic cycles are not eliminated by G-CSF, the period of the oscillations is shortened to 12-14 d. Based on a previously proposed computer-simulation model of human CN, the effects of continuous G-CSF application on CN are studied. It is shown how the known different cell-kinetic effects of G-CSF on granulopoiesis explain the clinical data in CN. The reduced length of the cycles emerges as a result of the transit time reduction of the post-mitotic granulopoietic cells by G-CSF. The measured increase of the neutrophil maxima is reproduced by the additional mitoses of the immature granulopoietic bone marrow cells induced by G-CSF. The slight elevation of the neutrophil nadirs can be attributed to a weak effect of G-CSF on the assu...Continue Reading

References

Oct 1, 1975·Scandinavian Journal of Haematology·L BrandtB Svensson
Jul 1, 1979·Scandinavian Journal of Haematology·N Jacobsen, H E Broxmeyer
Jul 1, 1977·Scandinavian Journal of Haematology·C DreschA Faille
Jan 1, 1976·American Journal of Hematology·P L GreenbergT M Andrews
Feb 1, 1992·European Journal of Haematology·L Danielsson, J Harmenberg
May 18, 1992·The Medical Journal of Australia·P V MarltonK M Taylor
May 18, 1989·The New England Journal of Medicine·W P HammondD C Dale
Jan 1, 1989·Cell and Tissue Kinetics·M LoefflerH E Wichmann
Sep 1, 1988·Blood Reviews·D C Dale, W P Hammond
Dec 1, 1973·The Journal of Clinical Investigation·D GuerryS M Wolff
May 1, 1974·British Journal of Haematology·M A MooreD G Penington
Jun 1, 1984·The Tohoku Journal of Experimental Medicine·M InoueN Matsumoto

❮ Previous
Next ❯

Citations

Jul 28, 2004·Journal of Mathematical Biology·Ivar Østby, Ragnar Winther
Mar 5, 2008·Journal of Mathematical Biology·Catherine Foley, Michael C Mackey
Oct 7, 2003·Mathematical Biosciences·Ivar ØstbyPer Grøttum
Jul 10, 2003·Journal of Theoretical Biology·Samuel BernardMichael C Mackey
Jul 2, 1999·Experimental Hematology·C HaurieM C Mackey
Aug 10, 2012·Journal of Biological Dynamics·Shinji Nakaoka, Kazuyuki Aihara
Jun 1, 1997·Journal of Clinical Gastroenterology·F FataM S Cappell
Dec 11, 2013·Current Opinion in Hematology·Akhil Maheshwari
Mar 29, 2001·Journal of Clinical Pathology·R Lakshman, A Finn
Mar 10, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·C Iglesias BlázquezJ M Marugán de Miguelsanz
Sep 13, 2014·Bulletin of Mathematical Biology·David C Dale, Michael C Mackey
Apr 29, 2009·Cell Proliferation·D DingliJ M Pacheco
Jun 25, 2005·Journal of Theoretical Biology·Caroline Colijn, Michael C Mackey
Jan 28, 2010·Blood·Zakary L WhichardSeth J Corey
Jun 2, 2000·Journal of Theoretical Biology·C HaurieM C Mackey
Jan 13, 2004·Lupus·N J AbbottD E M Dolman
Aug 1, 2006·Meditsinskaia tekhnika·N K SherepoV I Bronskiĭ
Jun 9, 2017·Nature Reviews. Disease Primers·Julia SkokowaKarl Welte

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.